These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16518836)

  • 21. Cost-utility analysis of cochlear implants in Korea using different measures of utility.
    Lee HY; Park EC; Kim HJ; Choi JY; Kim HN
    Acta Otolaryngol; 2006 Aug; 126(8):817-23. PubMed ID: 16846923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A theoretical framework for TTO valuations of health.
    Buckingham K; Devlin N
    Health Econ; 2006 Oct; 15(10):1149-54. PubMed ID: 16786547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.
    Günther O; Roick C; Angermeyer MC; König HH
    Drug Alcohol Depend; 2007 Jan; 86(2-3):253-64. PubMed ID: 16930855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of comorbidities on treatment decisions.
    Bleichrodt H; Crainich D; Eeckhoudt L
    J Health Econ; 2003 Sep; 22(5):805-20. PubMed ID: 12946460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
    Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
    Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility and reliability of the annual profile method for deriving QALYs for short-term health conditions.
    Janssen MF; Birnie E; Bonsel G
    Med Decis Making; 2008; 28(4):500-10. PubMed ID: 18420835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global cost-effectiveness of cataract surgery.
    Lansingh VC; Carter MJ; Martens M
    Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
    Gupta OP; Brown GC; Brown MM
    Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Danish EQ-5D population norms.
    Sørensen J; Davidsen M; Gudex C; Pedersen KM; Brønnum-Hansen H
    Scand J Public Health; 2009 Jul; 37(5):467-74. PubMed ID: 19535407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement.
    Attema AE; Brouwer WB
    Health Econ; 2008 Jul; 17(7):877-85. PubMed ID: 18074409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of an economic model of health states worse than dead.
    Sharma R; Stano M
    J Health Econ; 2010 Jul; 29(4):536-40. PubMed ID: 20633775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valuing avoided morbidity using meta-regression analysis: what can health status measures and QALYs tell us about WTP?
    Van Houtven G; Powers J; Jessup A; Yang JC
    Health Econ; 2006 Aug; 15(8):775-95. PubMed ID: 16544361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Not all "quality-adjusted life years" are equal.
    Marra CA; Marion SA; Guh DP; Najafzadeh M; Wolfe F; Esdaile JM; Clarke AE; Gignac MA; Anis AH
    J Clin Epidemiol; 2007 Jun; 60(6):616-24. PubMed ID: 17493521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the influence of gestalt-type characteristics on preferences over lifetime health profiles.
    Oliver A
    Med Decis Making; 2008; 28(5):723-31. PubMed ID: 18378938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.
    Boonen A; Patel V; Traina S; Chiou CF; Maetzel A; Tsuji W
    J Rheumatol; 2008 Apr; 35(4):662-7. PubMed ID: 18278836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
    Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
    Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of correcting values: influence and importance of correcting TTO scores for time preference.
    Attema AE; Brouwer WB
    Value Health; 2010 Dec; 13(8):879-84. PubMed ID: 20659269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A test of independence of discounting from quality of life.
    Attema AE; Brouwer WB
    J Health Econ; 2012 Jan; 31(1):22-34. PubMed ID: 22277284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The implications of linking questions within the SG and TTO methods.
    Spencer A
    Health Econ; 2004 Aug; 13(8):807-18. PubMed ID: 15322992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.